Journal article 42 views
Oral semaglutide and cardiovascular risk factors in high-risk type 2 diabetes: Post hoc analyses of a randomized clinical trial – SOUL
Sharon L. Mulvagh,
Silvio E. Inzucchi,
Nikolaus Marx,
Neil R. Poulter,
John E. Deanfield,
Rodica Pop-Busui,
Scott S. Emerson,
Johannes F. E. Mann,
Mads D. M. Engelmann,
G. Kees Hovingh,
Kabirdev Mandavya,
Zaklina Davicevic-Elez,
Ole Kleist Jeppesen,
Alberto Lorenzatti,
Aytekin Oguz,
Boris Mankovsky,
Chaicharn Deerochanawong, ,
Juan J. Gorgojo-Martinez,
Linong Ji,
Steve Bain 
,
Darren K. McGuire,
John B. Buse
,
Darren K. McGuire,
John B. Buse
JAMA Cardiology
Swansea University Author:
Steve Bain
Full text not available from this repository: check for access using links below.
Abstract
Oral semaglutide and cardiovascular risk factors in high-risk type 2 diabetes: Post hoc analyses of a randomized clinical trial – SOUL
| Published in: | JAMA Cardiology |
|---|---|
| ISSN: | 2380-6583 2380-6591 |
| Published: |
American Medical Association
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa71266 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|